Fitness Trends Global Pharmaceutical Excipients Market | Página 3

Market Taxonomy
This report segments the global pharmaceutical excipients market on the basis of chemistry,
functionality, application, and geography. On the basis of chemistry, the market is categorized
into plants, animals, minerals and synthetic sources. On the basis of functionality, the market is
segmented into binders, diluents, glidents, disintegrants, and others. The application segment is
divided into oral, parenteral, topical and others. For comprehensive understanding of market
dynamics, the global pharmaceutical excipients market is analyzed across key geographical
regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East.
Each of these regions is analyzed on basis of market findings across major countries in these
regions for a macro-level understanding of the market.
Oral and topical segment is driving the pharmaceutical excipients market growth
Excipients are largely used in the production of oral dosage forms such as tablets, capsules, and
liquids when compared to parenteral dosage forms. The growth of excipients usage in oral
dosage forms is expected to be 7.2% over the forecast period. Local players entering the
pharmaceutical industry mark their entry with oral dosage forms, as manufacturing of these are
easier when compared to other dosage forms. Economies such as India, Brazil, China, and U.S.
are few major pharmaceutical excipients markets, as they have large presence of regional
pharmaceutical players. Therefore, demand for excipients is expected to be high in such
economies. Moreover, growing topical solutions (cream, gel, eye drops, skin patch) in
dermatology and pain management categories is also expected to increase the demand for
excipients, thereby driving growth of the market.
Request For Customization of Research Report @ https://bit.ly/2NG2YbB
Key companies covered as a part of this study include BASF SE, The DOW Chemical Company,
Evonik Industries, FMC Corporation, Croda International PLC, Ashland Inc., Roquette Group,
Lubrizol Corporation, Innophos Holdings Inc. and MEGGLE Group Wasserburg BG Excipients &
Technology
Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars,
called PHASE-XS. This database provides analytical data in addition to the clinical information
of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters,
PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend,
competition, and market potential. For more information or to access this database, kindly click
on the below link or contact at [e-mail]